#cancer-research

#cancer-research

Normal cells with oncogenic mutations often do not become tumors due to an 'escape mechanism' linked to normal development, rather than cell death.

Cancer understanding has evolved to include not just genetic mutations but also epigenetic changes that influence gene expression.

Cancer development is influenced by both genetic mutations and epigenetic changes, highlighting the complexity of treatment and understanding.

Ali Shilatifard elected to National Academy of Sciences for his pioneering research in epigenetics and childhood leukemia.

The cancellation of key federal grants has jeopardized opportunities for deaf scientists and students.

U.S. cancer research relies on a complex, interdependent ecosystem vulnerable to disruptions that threaten progress and new treatments.

Young researchers are innovating in cancer drug development, focusing on pioneering techniques like cancer reversion to reduce the need for traditional treatments.

Dostarlimab immunotherapy shows promise for treating solid tumors with fewer severe side effects, achieving remarkable tumor regression in clinical trials.

Cancer is the second leading cause of death globally, requiring urgent advancements in diagnosis and treatment to keep pace with the rising incidence.

Emerging biopharmaceutical companies are increasingly dominating the oncology clinical trial landscape, reflecting their growing importance in cancer research.

Combining targeted therapies with traditional treatments enhances the fight against aggressive liver cancer, marking a significant therapeutic advancement.

Brexit is complicating cancer trials in the UK, raising costs and causing delays, preventing patients from accessing new treatments.

The eSMART trial faces significant logistical challenges post-Brexit.

The FDA has removed online resources related to diversity in clinical trials, affecting initiatives for inclusive drug evaluations.

Vitamin D is effective in preventing and treating colorectal cancer, enhancing immune response and reducing inflammation.

Colorectal cancer cases among individuals under 50 are rising, signaling a worrying trend that contradicts traditional perceptions of health and lifestyle.

Colorectal cancer has doubled in individuals under 55, potentially linked to the colibactin toxin produced by E. coli.

The majority of younger colorectal cancer patients exhibit mutations associated with past colibactin exposure.

China surpassed the U.S. in cancer research output for the first time in 2024.

Collaboration across different research specialties is key to advancing cancer biology and therapeutic strategies.

A new AI model, General Expression Transformer (GET), predicts gene behavior, aiding in understanding cancer and genetic diseases.

The development of a comprehensive catalog of transcription factor binding sites enhances the understanding of gene regulation related to cancer and developmental disorders.

Band of Parents raises funds for neuroblastoma research to improve survival rates for children.

Awesome Games Done Quick 2025 raised over $2.5 million for the Prevent Cancer Foundation, continuing its legacy of impactful charity gaming.

Slimming World members raised £7,500 for charity by donating clothes they had outgrown as part of a community initiative.

mRNA technology's success in COVID vaccines is paving the way for personalized cancer vaccines.

Dr. Soon-Shiong links COVID-19 and its vaccines to a rise in aggressive cancers in young people.

Metformin works by reducing the cell's energy supply by interfering with mitochondria, a key discovery on its mechanism of action in lowering blood sugar.

Experts recommend moderating the use of certain cooking oils due to links between linoleic acid and aggressive breast cancer.

Ribosome profiling revealed the existence of 'dark proteins' produced from previously unknown genomic regions.

Vimentin protein's structure and function are crucial for cellular healing processes, offering insights into wound healing and broader implications for cancer.

Mitochondria are dynamic and complex structures, not just bean-shaped, challenging traditional perceptions.

Research on restoring fertility in childhood cancer survivors is underway, using sperm-producing stem cells.

Jaiwen Hsu is the first recipient of stem cells aimed at restoring fertility post-cancer.

Cure51 aims to revolutionize oncology by creating the first global database of cancer survivors and seeking new treatments based on survivor data.

The rise in early-onset cancer is concerning, highlighting the need for better awareness and preventive measures.

Lifestyle factors may contribute significantly to the increasing rates of cancer in younger adults.

Trump's administration has paused critical funding for cancer research and medical projects, disrupting NIH operations and creating uncertainty in ongoing and future trials.

Continued research funding is crucial for combating glioblastoma and other cancers, especially given recent budget cuts.

Exportin-1 plays a critical role in gene transcription in addition to its known function in nucleocytoplasmic transport.

Sylvie Beljanski champions natural cancer solutions through her foundation and innovative health products inspired by her father's groundbreaking research.

Sugary soda consumption is significantly linked to a higher risk of oral cancer in women.

Bowel cancer rates are rising among younger adults globally, with a 3.6% annual increase in England, necessitating awareness of early signs.

Cancer cells can transfer defective mitochondria to immune cells, leading to immune evasion.

Research reveals the previously unknown migration of mitochondria in human cells.

The research showcases collaboration across departments to study microbial pathogenesis and its role in diseases such as AIDS and cancer.

Genetically engineered mice were essential for studying immune responses in cancer research under ethical guidelines.

Aspirin may disrupt cancer cell evasion mechanisms, aiding immune system response against them.

AI and quantum computing can create novel anti-cancer drugs targeting previously untreatable proteins.

A breakthrough in cancer research identifies a critical protein for chordoma treatment, offering new hope for effective therapies.

Earli aims to revolutionize early cancer detection through innovative science and technology.

Bhad Bhabie's $BHAD token emphasizes transparency and community, aiming to support cancer research and engage fans meaningfully.

Reid Hoffman advocates that AI enhances human capabilities and overcomes information challenges.

Manas AI, co-founded by Reid Hoffman, is an AI-driven startup focusing on drug discovery for major cancers, raising $24.6 million in seed funding.